KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Xylem (XYL) Receivables - Other (2023)

Xylem has reported Receivables - Other over the past 1 years, most recently at $5.0 million for Q4 2023.

For Q4 2023, Receivables - Other changed N/A year-over-year to $5.0 million; the TTM value through Dec 2023 reached $5.0 million, changed N/A, while the annual FY2023 figure was $5.0 million, N/A changed from the prior year.
Receivables - Other for Q4 2023 was $5.0 million at Xylem.
Over five years, Receivables - Other peaked at $5.0 million in Q4 2023 and troughed at $5.0 million in Q4 2023.